Has Boston Scientific Corporation had other FDA enforcement actions?

Yes. Argus HQ has recorded 273 total FDA actions tied to Boston Scientific Corporation: 0 warning letters, 273 recalls, 0 approval records, and 0 Form 483 inspection citations.

What kind of FDA record is this?

This is an Argus HQ record of a FDA Recall, tagged high severity by Argus HQ. FDA published the underlying record on 2026-07-22; Argus observed and indexed it on 2026-07-28.

Where can I verify this record directly with FDA?

The verbatim FDA source record is the source of truth — Argus HQ links directly to it below. Always confirm against fda.gov before acting.

.hq

fda_recall · device_recall · high

Boston Scientific Corporation — Class II recall: Rapid Refill Continuous Injection System, UPN M00566001

Name: FDA Recall Record — Boston Scientific Corporation
Creator: Argus HQ
Published: 2026-07-22
License: https://argushq.ai/methodology

Event date: 2026-07-22 00:00:00Z
Observed: 2026-07-28 04:20:55Z
Source ID: Z-2725-2026
Payload hash: 2808d03b3dd2fdaf952a1e3b…

Summary

Devices contain recalled Medline Namic Angiographic Control Syringe with Rotating Adaptor. There is a risk of syringe loosening or disconnecting from the manifold, resulting in loose connection or complete disconnection. May lead to difficulty connecting syringe, inability to aspirate or inject prop… Status: Ongoing.

Entities

Boston Scientific Corporation

View source record ↗

Frequently asked questions

Has Boston Scientific Corporation had other FDA enforcement actions?: Yes. Argus HQ has recorded 273 total FDA actions tied to Boston Scientific Corporation: 0 warning letters, 273 recalls, 0 approval records, and 0 Form 483 inspection citations.
What kind of FDA record is this?: This is an Argus HQ record of a FDA Recall, tagged high severity by Argus HQ. FDA published the underlying record on 2026-07-22; Argus observed and indexed it on 2026-07-28.
Where can I verify this record directly with FDA?: The verbatim FDA source record is the source of truth — Argus HQ links directly to it below. Always confirm against fda.gov before acting.

Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder

Cite this record

Reusing this data in reporting or research? Here’s a ready-made citation.

APA

Argus HQ Research (2026). Boston Scientific Corporation — Class II recall: Rapid Refill Continuous Injection System, UPN M00566001. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/events/fda-recall-boston-scientific-corporation-z-2725-2026

MLA

"Boston Scientific Corporation — Class II recall: Rapid Refill Continuous Injection System, UPN M00566001." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/events/fda-recall-boston-scientific-corporation-z-2725-2026.

Chicago

Argus HQ Research. "Boston Scientific Corporation — Class II recall: Rapid Refill Continuous Injection System, UPN M00566001." Digital Empire Holdings LLC. Accessed July 28, 2026. https://argushq.ai/events/fda-recall-boston-scientific-corporation-z-2725-2026.

BibTeX

@misc{argushq_argushq_ai_events_fda_recall_boston_scientific_corporation_z_2725_2026_2026,
  title = {Boston Scientific Corporation — Class II recall: Rapid Refill Continuous Injection System, UPN M00566001},
  author = {{Argus HQ Research}},
  year = {2026},
  publisher = {Digital Empire Holdings LLC},
  url = {https://argushq.ai/events/fda-recall-boston-scientific-corporation-z-2725-2026},
  note = {Accessed: July 28, 2026}
}

Informational only. Not legal, financial, or medical advice.